Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 3.

Baird, Anne-Marie; Easty, David; Jarzabek, Monika; Shiels, Liam; Soltermann, Alex; Klebe, Sonja; Raeppel, St├ęphane; MacDonagh, Lauren; Wu, Chengguang; Griggs, Kim; Kirschner, Michaela B; Stanfill, Bryan; Nonaka, Daisuke; Goparaju, Chandra M; Murer, Bruno; Fennell, Dean A; O'Donnell, Dearbhaile M; Barr, Martin P; Mutti, Luciano; Reid, Glen; Finn, Stephen; Cuffe, Sinead; Pass, Harvey I; Opitz, Isabelle; Byrne, Annette T; O'Byrne, Kenneth J; Gray, Steven G (2019). When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All? Frontiers in Endocrinology, 10:89.

Johnson, Thomas G; Schelch, Karin; Cheng, Yuen Y; Williams, Marissa; Sarun, Kadir H; Kirschner, Michaela B; Kao, Steven; Linton, Anthony; Klebe, Sonja; McCaughan, Brian C; Lin, Ruby C Y; Pirker, Christine; Berger, Walter; Lasham, Annette; van Zandwijk, Nico; Reid, Glen (2018). Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 13(2):258-272.

Cheng, Yuen Yee; Wright, Casey M; Kirschner, Michaela B; Williams, Marissa; Sarun, Kadir H; Sytnyk, Vladimir; Leshchynska, Iryna; Edelman, J James; Vallely, Michael P; McCaughan, Brian C; Klebe, Sonja; van Zandwijk, Nico; Lin, Ruby C Y; Reid, Glen (2016). KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma. Molecular Cancer, 15:44.

This list was generated on Wed Sep 18 18:46:49 2019 CEST.